Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.
Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional - and often ineffective - advice to "eat ...
Robert F. Kennedy Jr., nominated to lead HHS under President Donald Trump's second term, brings a range of healthcare positions that could directly and indirectly influence public health, ...